Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DANTROLENE vs DAPAGLIFLOZIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DANTROLENE vs DAPAGLIFLOZIN: Safety Overview

Metric DANTROLENE DAPAGLIFLOZIN
Total FAERS Reports 298 21,367
Deaths Reported 39 3,633
Death Rate 13.1% 17.0%
Hospitalizations 150 8,467
Average Patient Age 43.9 yrs 64.9 yrs
% Female Patients 41.2% 44.5%
FDA Approval Date Approved Prior to Jan 1, 1982 Jan 8, 2014
Manufacturer American Health Packaging AstraZeneca Pharmaceuticals LP
Route ORAL ORAL
Marketing Status Prescription Prescription